Genetic Testing in Guiding Treatment for Patients With Brain Metastases
Genetic Testing in Guiding Treatment for Patients With Brain Metastases
Active, not recruiting · NCT03994796 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Genetic Testing in Guiding Treatment for Patients With Brain Metastases | Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system cancer, central nervous system disorder, metastatic malignant neoplasm in the brain, neoplasm, nervous system disorder | Active, not recruiting | Phase 2 | 2026-09-28 | NCT03994796 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alliance for Clinical Trials in Oncology | 79 |
| Eli Lilly and Company | 370 |
| Genentech, Inc. | 221 |
| Kazia Therapeutics Limited | 5 |
| Mirati Therapeutics Inc. | 14 |
| National Cancer Institute (NCI) | 3015 |
435 results · Page 1 of 18
Research sites
Swipe the table sideways for more columns.